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Abstract: Patients with achondroplasia and other causes of dwarfism suffer from increased rates of 
cardiovascular disease relative to the remainder of the population. Few studies have examined these patients 
when undergoing cardiac surgery or percutaneous intervention. This systematic review examines the 
literature to determine outcomes following cardiac intervention in this unique population. An electronic 
search was performed in the English literature to identify all reports of achondroplasia, dwarfism, and 
cardiac intervention. Of the 5,274 articles identified, 14 articles with 14 cases met inclusion criteria. Patient-
level data was extracted and analyzed. Median patient age was 55.5 [interquartile ranges (IQR), 43.8, 59.8] 
years, median height 102.0 [98.8, 112.5] cm, median BMI 32.1 [27.0, 45.9], and 57.1% (8/14) were male. 
Of these 14 patients, nine had the following documented skeletal abnormalities: 66.7% (6/9) had scoliosis, 
66.7% (6/9) had kyphosis, 11.1% (1/9) had lordosis, 11.1% (1/9) pectus carinatum and 11.1% (1/9) spinal 
stenosis. Coronary artery disease was present in 53.8% (7/13), and 30.8% (4/13) patients previously suffered 
a myocardial infarction. Of the eight patients who underwent cardiac surgery, 37.5% (3/8) underwent 
multivessel coronary artery bypass grafting, 37.5% (3/8) underwent aortic valve replacement, 25.0% 
(2/8) underwent type A aortic dissection repair, and the remaining 12.5% (1/8) underwent pulmonary 
thromboendarterectomy. Six patients underwent percutaneous intervention. Median cardiopulmonary 
bypass time was 136.5 [110.0, 178.8] minutes. Median arterial cannula size was 20.0 [20.0, 24.0] Fr. Bicaval 
cannulation was performed in all cases describing cannulation strategy (5/5). Median superior vena cava 
cannula size was 28.0 [28.0, 28.0] Fr, and inferior vena cava cannula size was 28.0 [28.0, 28.0] Fr. No 
mortality was reported with a median follow up time of 6.0 [6.0, 10.5] months. In conclusion, Common 
cardiac procedures can be performed with reasonable safety in this patient population. Operative adjustments 
may need to be made with respect to equipment to accommodate patient-specific needs.
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Introduction
Achondroplasia and other causes of dwarfism represent a 
minority of the overall population but only have slightly 
shorter mean lifespans than non-dwarfs, 61 versus 
71 years (1-3). With fairly long life spans, dwarfs are likely 
to suffer from similar comorbidities as that of aging general 
population. This population represents 0.36 to 0.60 per 
10,000 live births, a minority group, but one that must 
be considered with respect to interventions that may be 
required of all aging groups (3). In particular, dwarfs have 
an increased risk for cardiovascular disease and heart-
disease related deaths. Between the ages of 25 to 35, dwarfs 
have a tenfold increase in risk of mortality from heart-
related disease (4). This has been hypothesized to be due 
to a propensity for arterial occlusion of narrower vessels 
due to atherosclerosis in individuals of shorter stature (2). 
Since this population has an increased risk of cardiovascular 
disease, there is increased likelihood that dwarfs may 
require percutaneous or invasive intervention to mitigate 
atherosclerotic disease. This study examines a series of 
case reports that have noted cardiac interventions in this 
patient population and evaluates their safety, efficacy, and 
outcomes.
Whi le  there  are  mult ip le  causes  of  dwarf i sm, 
achondroplasia is the most prevalent, accounting for more 
than 90% of short stature individuals (5). It is inherited in an 
autosomal-dominant fashion, and is fully penetrant. Despite 
this inheritance pattern, 90% of cases are sporadic and 
due to mutations in G1138A or G1138C in the fibroblast 
growth factor 3 gene on chromosome 4p16.3 (5). This 
results in a skeletal dysplasia with small stature, short limbs 
with rhizomelic proportions, macrocephaly, a small chest, 
thoracolumbar kyphosis, and lumbar hyperlordosis (5). 
These anatomic variations can profoundly affect a patient’s 
life but also must be understood by the clinician as 
procedures will need to be tailored to the patient in order to 
be successful.
Given these anatomic variations, Dwarfism has been 
noted to be challenging for multiple medical providers 
including the anesthetic clinician (6-8). As this population 
ages, clinicians will need to be prepared to provide necessary 
procedures to these individuals. Due to the increased 
cardiovascular risks and a near normal life expectancy, it is 
possible that people with dwarfism will need to undergo 
cardiac intervention.
This systematic review examines 14 cases of patients 
with achondroplasia undergoing cardiac procedures. As far 
as the authors know, these are the only cases documented 
in the English medical literature noting individuals with 
achondroplasia undergoing cardiac intervention. By pooling 
this data, we hope to evaluate the safety and efficacy of 
these procedures, especially with the knowledge that this 
population is particularly vulnerable to cardiovascular 
disease.
Methods
Literature search strategy
Thorough electronic searches were performed in January 
2019 using MEDLINE (Ovid SP), Scopus, CCRT, 
CINAHL, and PubMed. To achieve the maximum 
sensitivity of the search strategy, the following combined 
terms were used: “Dwarfism or Achondroplasia or Receptor, 
Fibroblast Growth Factor, Type 3, or achondroplast”, 
“Limb deformities, congenital, or osteochondrodysplasias, 
or cartilage, or skeletal dysplasia”, “rhizomelic or 
chondrodysplasia”, “cardiac catheterization”, “cardiac 
catheterization or cardiac surgical procedures or cardiac”, 
“heart atria or heart valves or heart ventricles”, “aorta or 
aortic aneurysm”, “coronary vessel anomalies”, “dwarf”, 
The reference lists of all eligible studies were reviewed 
for further identification of potentially relevant studies 
and assessed using the inclusion and exclusion criteria. A 
PRISMA flow diagram depicting the overall search strategy 
is provided in Figure 1.
Selection criteria
Eligible articles for the present systematic review included 
case reports/series that focused on patients undergoing 
cardiac intervention with dwarfism. Patients less than 
16 years of age were excluded. Reports not published in 
the English language, abstracts, conference presentations, 
editorials, reviews and expert opinions were also excluded. 
Of the 5,274 articles identified, 14 articles met inclusion 
criteria consisting of 14 patients. Patient-level data were 
extracted and analyzed.
Data extraction and critical appraisal
Data were extracted from article texts, tables, and figures 
(AS, JC). Discrepancies between the reviewers were 
resolved by discussion and consensus. When data were not 
available, attempts were made to contact the corresponding 
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authors to obtain the relevant data for the current study.
Statistical analysis
Baseline characteristics and demographics were reported 
using descriptive statistics, including medians and 
interquartile ranges (IQR) for continuous data and 
percentages for categorical data.
Evaluation of missing data
Given the nature of this systematic review with data 
obtained from individual case reports, not all articles shared 
the same variables. This discrepancy was evaluated in terms 
of treatment of missing data and according adjustment 
of the denominator determining percentage values. 
Missing data in the routine variables such as demographic 
variables were treated as missing at random, while variables 
representing major adverse events were assumed to not have 
occurred if not reported.
Results
Study characteristics
Overall, 5,274 articles were identified in the literature 
search. Following application of the selection criteria, 
a total of 14 case reports consisting of 14 patients were 
included in the analysis. A manual search of references was 
Figure 1 PRISMA schematic diagram of the search strategy. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-
Analysis.
Studies identified by search of MEDLINE, Scopus, CCRT, 
CINAHL, and PubMed 
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performed and did not reveal any additional studies.
Baseline characteristics
Median patient age was 55.5 [IQR, 43.8, 59.8] years, 
median height was 102.0 [98.8, 112.5] cm, median BMI was 
32.1 [27.0, 45.9], and 57.1% (8/14) were male. Of these 
14 patients, nine had the following documented skeletal 
abnormalities: 66.7% (6/9) had scoliosis, 66.7% (6/9) had 
kyphosis, 11.1% (1/9) had lordosis, 11.1% (1/9) pectus 
carinatum or 11.1% (1/9) spinal stenosis. With respect to 
comorbidities placing patients at risk for coronary events, 
53.8% (7/13) had coronary artery disease, 55.6% (5/9) 
had hypertension, 55.6% (5/9) hypercholesterolemia, and 
50.0% (4/8) had a smoking history. 30.8% (4/13) patients 
previously suffered a myocardial infarction. Details on 
baseline characteristics are outlined in Table 1.
Pre-operative characteristics
Pre-operatively, the median left ventricular ejection fraction 
was 50% [40, 60]. Coronary artery disease was present in 
53.8% (7/13) of patients. Right coronary artery stenosis 
was present in 75.0% (6/8) of patients. This was followed 
by 71.4% (5/7) of patients with left anterior descending 
stenosis, 57.1% (4/7) of patients with circumflex stenosis. 
In total 50.0% (3/6) patients presented with ST segment 
elevation. With respect to those with valvular disease, 
21.4% (3/14) had aortic stenosis. Of these patients, the 
median maximum aortic valve transvalvular gradient 
was 114.5 [99.8, 129.2] mmHg. Additional preoperative 
characteristics are demonstrated in Table 2.
Operative variables
We examined the patient population who underwent two 
different sets of interventions: surgery and percutaneous 
intervention. Of these, 57.1% (8/14) patients underwent 
surgery and 42.9% (6/14) underwent percutaneous 
intervention. Within the surgery group, 37.5% (3/8) 
underwent multivessel coronary artery bypass grafting, 
37.5% (3/8) underwent aortic valve replacement, one of 
which was during a concomitant Type A aortic dissection 
repair, 25.0% (2/8) underwent type A aortic dissection 
repair,  and the remaining 12.5% (1/8) underwent 
pulmonary thromboendarterectomy. Of the percutaneous 
group, 66.7% (4/6) underwent percutaneous coronary 
intervention, 16.7% (1/6) underwent balloon aortic 
valvuloplasty and balloon pulmonary valvuloplasty, and 
16.7% (1/6) underwent micra transcatheter pacing system 
implantation.
Of the patients who had surgery performed, 100.0% 
(8/8) underwent cardiopulmonary bypass (CPB) with a 
median aortic cross clamp time of 91.0 [67.5, 96.5] minutes 
and a total cardiopulmonary bypass time of 136.5 [110.0, 
178.8] minutes. Arterial cannula size was 20.0 [20.0, 24.0] 
Fr. Bicaval cannulation was performed in all cases (5/5). 
Table 1 Patient demographics
Variable Total (n=14)
Patient characteristics
Age, median [IQR] 55.5 [43.8, 59.8]
Male, % (n/N) 57.1 (8/14)
Height (cm), median [IQR] 102.0 [98.8, 112.5]
Weight (kg), median [IQR] 40.5 [29.5, 45.6]
BSA (m2), median [IQR] 1.1 [0.9, 1.2]
BMI (kg/m2), median [IQR] 32.1 [27.0, 45.9]
No family history of achondroplasia, % 
(n/N)
35.7 (5/14)
Skeletal abnormalities
Scoliosis, % (n/N) 66.7 (6/9)
Kyphosis, % (n/N) 66.7 (6/9)
Lordosis, % (n/N) 11.1 (1/9)
Pectus carinatum, % (n/N) 11.1 (1/9)
Spinal stenosis, % (n/N) 11.1 (1/9)
Medical history
Hypertension, % (n/N) 55.6 (5/9)
Hypercholesterolemia, % (n/N) 55.6 (5/9)
Type 2 diabetes, % (n/N) 22.2 (2/9)
Coronary artery disease, % (n/N) 53.8 (7/13)
History of MI, % (n/N) 30.8 (4/13)
Smoking history, % (n/N) 50.0 (4/8)
History of transient ischemic attack, % 
(n/N)
7.1 (1/14)
Obstructive sleep apnea, % (n/N) 7.1 (1/14)
BSA, body surface area; BMI, body mass index; MI, myocardial 
infarction; IQR, interquartile range.
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Superior vena cava cannula size was 28.0 [28.0, 28.0] Fr with 
a maximum size of 30 Fr, and inferior vena cava cannula 
size was 28.0 [28.0, 28.0] Fr with a maximum size of 30 Fr. 
With respect to aortic valve replacement, the sizes of the 
implanted valve prostheses were 16 mm [14], 20 mm [15], 
and 23 mm [9], respectively. The median aortic root size 
was 11.0 [10.5, 31.5] mm with 33.3% (1/3) of patients 
undergoing aortic root enlargement. In this patient, 
root enlargement was accomplished by extending the 
incision through the noncoronary Sinus of Valsalva along 
the subaortic space and patching it with autologous 
pericardium (9). Further operative details can be found in 
Table 3.
Outcomes and complications
Post-operatively, patients spent a median of 2 [1, 5] days in 
the intensive care unit with a median hospital length of stay 
of 7 [5, 15] days. The postoperative aortic valve gradient 
was 11.0 [9.5, 13.5] mmHg. One patient was centrally 
cannulated for veno-arterial extracorporeal life support 
following pulmonary artery endarterectomy. All patients 
(14/14) were asymptomatic relative to coronary symptoms 
at the time of discharge with a median follow up time of 
6.0 [6.0, 10.5] months and continued to be asymptomatic 
at follow up (10/10). None of the cases reported mortality 
with a median follow up time of 6.0 [6.0, 10.5] months. 
Additional information regarding postoperative outcomes 
and complications can be found in Tables 4 and 5.
Discussion
Achondroplastic dwarfism represents a clinical challenge 
for surgeons and clinicians given differences in anatomy 
and physiology. Given a relatively similar lifespan 
as the general population and a propensity for early 
cardiovascular disease, it is not uncommon for these 
patients to develop long-term health problems and require 
cardiac intervention. The risk of heart disease is twice as 
high in achondroplastic dwarfs compared to the general 
population and three times as high when comparing male 
achondroplastic dwarfs with the general population (4). 
With studies noting increased cardiovascular risk in patients 
with achondroplasia, it stands to reason that these patients 
will require intervention in the future. These patients 
require special procedural considerations with respect to 
anesthesia, operative technique, and postoperative care. 
These considerations have been evaluated previously with 
respect to other operations, but cardiac interventions have 
not been previously examined on a scale larger than case 
reports. Our data demonstrated excellent survival, minimal 
complications, and excellent secondary outcomes. It should 
be noted the inherent bias in obtaining this data from 
individual case reports which is noted in our limitations 
discussion.
With respect to achondroplastic dwarfs, considerations 
had to be made to adjust procedures to differences in patient 
anatomy and physiology. From an anesthesia perspective, 
the kyphotic cervical spine, maxillary hypoplasia and 
megalencephaly can present difficult airway challenges in 
patients with dwarfism (6). In the case reports that detailed 
the intubation process, all three cases used a method of 
video-assisted intubation. Anesthetic literature has also 
suggested using smaller endotracheal tubes basing the size 
on the weight of the patient (6). In our patient cohort, 
35.7% (5/14) patients required pediatric endotracheal 
tubes. The remaining nine case reports did not specify the 
type or size of the endotracheal tube. Following intubation, 
intravascular access and patient positioning are both 
challenging due to short limbs, reduced joint mobility, and 
Table 2 Preoperative characteristics
Variable Total (n=14)
Ejection fraction % (n/N), median [IQR] 50 [40, 60]
Coronary artery disease 53.8 (7/13)
Right coronary artery stenosis, % (n/N) 75.0 (6/8)
Left anterior descending stenosis, % (n/N) 71.4 (5/7)
Circumflex stenosis, % (n/N) 57.1 (4/7)
ST elevation, % (n/N) 50.0 (3/6)
Aortic stenosis, % (n/N) 21.4 (3/14)
Hypertrophic interventricular septum 66.7 (2/3)
Interventricular septum size (mm), median [IQR] 14.0 [13.5, 14.5]
Left ventricular hypertrophy, % (n/N) 33.3 (1/3)
Maximum aortic valve transvalvular gradient 
(mmHg), median [IQR]
114.5 [99.8, 
129.2]
Aortic valve area (cm2), median [IQR] 0.5 [0.5, 0.5]
Pulmonary stenosis, % (n/N) 7.1 (1/14)
Mean pulmonary artery pressure (mmHg), 
median [IQR]
45.0 [39.0, 51.5]
Preoperative atrial fibrillation, % (n/N) 7.1 (1/14)
IQR, interquartile range.
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anatomy of the chest (8). Several reports note the use of 
ultrasound guidance for intravascular access and arterial and 
vein cut-downs for safe vascular exposure (10,11). These 
differences from the general population must be considered 
in preparing for procedures on patients with achondroplasia.
With respect to cardiac surgery interventions in these 
patients, several operative techniques should be adjusted 
or considered prior to and during the case. For procedures 
requiring CPB, smaller cannula sizes were used in general. 
It should be noted that all five cases where cannulation was 
documented reported bicaval cannulation. This was likely 
performed due to crowding from relatively large organs in a 
Table 3 Intraoperative characteristics
Variable Total (n=14)
Surgery, % (n/N) 57.1 (8/14)
Multivessel CABG, % (n/N) 37.5 (3/8)
Aortic valve replacement, % (n/N) 37.5 (3/8)
Type A aortic dissection repair, % (n/N) 25.0 (2/8)
Pulmonary thromboendarterectomy, % 
(n/N)
12.5 (1/8)
Percutaneous intervention, % (n/N) 42.9 (6/14)
Percutaneous coronary intervention, % 
(n/N)
66.7 (4/6)
Balloon aortic valvuloplasty and balloon 
pulmonary valvuloplasty, % (n/N)
16.7 (1/6)
Micra transcatheter pacing system 
implantation, % (n/N)
16.7 (1/6)
Intubation method
Fiberoptic scope, % (n/N) 33.3 (1/3)
Glidescope, % (n/N) 33.3 (1/3)
Video laryngoscopy, % (n/N) 33.3 (1/3)
Pediatric endotracheal tube, % (n/N) 35.7 (5/14)
Cardiopulmonary bypass, % (n/N) 100.0 (8/8)
Temperature
Normothermia (>34 ℃), % (n/N) 25.0 (2/8)
Mild hypothermia (28.1–34 ℃), % (n/N) 12.5 (1/8)
Moderate hypothermia (20.1–28 ℃), % 
(n/N)
12.5 (1/8)
Deep hypothermia (14.1–20 ℃), % (n/N) 25.0 (2/8)
Circ arrest time (minutes), median [IQR] 40.0 [29.5, 50.5]
CPB time (minutes), median [IQR] 136.5 [110.0, 178.8]
Arterial cannulation site
Aorta, % (n/N) 60.0 (3/5)
Axillary, % (n/N) 20.0 (1/5)
Femoral, % (n/N) 20.0 (1/5)
Arterial cannula size (Fr), median [IQR] 20.0 [20.0, 24.0]
Bicaval cannulation 100.0 (5/5)
Superior vena cava cannula size (Fr), 
median [IQR]
28.0 [28.0, 28.0]
Inferior vena cava cannula size (Fr), 
median [IQR]
28.0 [28.0, 30.0]
Table 3 (continued)
Table 3 (continued)
Variable Total (n=14)
Coronary artery bypass grafting
Vein harvested
Left saphenous, % (n/N) 33.3 (1/3)
Right and left saphenous, % (n/N) 33.3 (1/3)
Right saphenous, % (n/N) 33.3 (1/3)
Vein quality
Normal, % (n/N) 66.7 (2/3)
Moderate, % (n/N) 33.3 (1/3)
Artery harvested
LIMA, % (n/N) 66.7 (2/3)
LIMA and RIMA, % (n/N) 33.3 (1/3)
Artery quality
Normal, % (n/N) 100.0 (2/2)
Aortic valve replacement
Aortic cross clamp time (minutes), 
median [IQR]
91.0 [67.5, 96.5]
Prosthetic valve type
Carbomedics, % (n/N) 33.3 (1/3)
Mechanical, bileaflet, % (n/N) 33.3 (1/3)
Perceval S aortic valve, % (n/N) 33.3 (1/3)
Aortic root size (mm), median [IQR] 11.0 [10.5, 31.5]
Aortic root enlargement, % (n/N) 33.3 (1/3)
CABG, coronary artery bypass grafting; circ, circulation; CPB, 
cardio-pulmonary bypass; LIMA, left internal mammary artery; 
RIMA, right internal mammary artery; IQR, interquartile range.
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smaller chest cavity. One report noted that surgeons should 
assess patients for the largest possible cannulation sizes for 
CPB to eliminate the possibility of reduced flow that may 
compromise end-organ perfusion (11). For procedures 
requiring artery or vein conduit, it should be noted that 
saphenous vein graft may be challenging to obtain, too short 
for purposes of a bypass, or unsuitable for bypass. One such 
report noted smaller length of saphenous vein harvest with 
moderate quality due to patient anatomy and performed 
a three-vessel coronary-artery bypass with both right and 
left internal mammary arteries (10). Another report noted a 
29 cm saphenectomy incision that extended to the patient’s 
ankle (12), and a third noted pre-operative phlebography to 
assess for vein quality (13). A third report noted unsuitable 
grafts given the severe musculoskeletal changes (14). Once 
median sternotomy was performed, reports noted concerns 
regarding organ crowding with respect to the patient’s 
chest anatomy, but found chest and organ size consistent 
with the general population (10,11). However, due to some 
thinning of the sternum, one such report noted closure 
with absorbable suture in lieu of stainless steel wire (9). 
With respect to aortic valve replacement, our investigation 
noted the placement of valves required surgical aortic root 
enlargement in one case (9) with aortic root dilation in 
another case (15). These technical considerations must be 
considered prior to performing any cardiac intervention on 
patients with achondroplasia.
Aortic procedures in these patients also have unique 
considerations. Two patients presented with type A 
dissection and underwent subsequent hemiarch repairs. Due 
to the small caliber of their major vessels, the feasibility of 
cerebral perfusion was initially in question. However, the 
authors did not encounter any difficulty with antegrade 
selective cerebral perfusion in these patients. One patient 
underwent central arterial and venous cannulation, while 
another patient underwent peripheral arterial cannulation 
but central venous cannulation.
With respect to percutaneous interventions in patients 
with achondroplasia, our systematic review of available 
interventions in this population demonstrates safe and 
effective use of these techniques to alleviate and treat 
cardiovascular conditions in these patients. Studies have 
noted technical difficulties with endovascular access of the 
coronary arteries using the transradial approach due to short 
limbs, elbow angles and kyphoscoliosis (16,17). Obtaining 
arterial access has also been noted to be challenging with 
respect to accessing the femoral vessels, and one study 
noted ultrasonographic assistance was required (14). 
Determination of radial versus femoral access should be 
determined on a case-by-case basis with the two reports of 
radial access noting their choice was based on complexity 
of intervention required (17,18). Further studies are 
necessary to elucidate the benefits and disadvantages of each 
technique. Although obtaining coronary access was difficult, 
no challenges with respect to coronary morphology were 
encountered. In total these six reports noted success at 
achieving revascularization or elimination of stenosis with 
minimal complication.
Evaluation of both surgical and percutaneous techniques 
revealed several suggestions by each of these case reports. 
Unfortunately, due to the number of cases in total, these 
recommendations are areas that require further study. 
For surgical intervention, these case reports suggest the 
Table 4 Postoperative characteristics
Variable Total (n=14)
Time in ICU (days), median [IQR] 2 [1, 5]
Number of postoperative days in hospital, median 
[IQR]
7 [5, 15]
Postoperative aortic valve gradient (mmHg), 
median [IQR]
11.0 [8.5, 13.5]
Postoperative complications
VA ECMO, % (n/N) 7.1 (1/14)
Mediastinal bleeding, % (n/N) 7.1 (1/14)*
Pleural effusion, % (n/N) 7.1 (1/14)*
Pneumothorax, % (n/N) 7.1 (1/14)*
Pulmonary embolism, % (n/N) 7.1 (1/14)*
Atrial fibrillation, % (n/N) 7.1 (1/14)
*, same patient who had undergone coronary artery bypass 
grafting. ICU, intensive care unit; IQR, interquartile range; VA 
ECMO, veno-arterial extracorporeal membrane oxygenation.
Table 5 Outcomes
Variable Total (n=14)
Asymptomatic at discharge, % (n/N) 100.0 (14/14)
Follow up time (months), median [IQR] 6.0 [6.0, 10.5]
Asymptomatic at last follow up, % (n/N) 100.0 (10/10)
30-day mortality, % (n/N) 0.0 (0/14)
Overall mortality, % (n/N) 0.0 (0/14)
IQR, interquartile range.
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following: videoscopic intubation with smaller endotracheal 
tubes, obtain intravascular access using ultrasonography 
and arterial cutdown where necessary, use the largest 
available cannula size that vessels can accommodate with 
pediatric sized cannulas available, perform preoperative 
phlebography of saphenous veins if being used as conduits, 
and if aortic valve replacement is required, consider aortic 
root enlargement or dilation for appropriate fitting of 
the replacement valve. With respect to percutaneous 
intervention, clinicians should be aware of the challenges of 
coronary vessel cannulation and the relative advantages and 
disadvantages of radial versus femoral access with respect to 
patient anatomy using ultrasonography when able for vessel 
access.
This systematic review has demonstrated performing 
surgical and percutaneous interventions in dwarfs is both 
safe and effective though further study is needed to ensure 
this is not due to a selective publishing of favorable cases. 
Operative and procedural considerations must be made 
to ensure success though these can be accomplished 
with expert care and preoperative planning. Further, a 
prospective registry would be beneficial to determine 
best practices. Given the pre-operative concerns of organ 
size and crowding shared by the articles included in 
this systematic review, it is possible that this sentiment 
is shared by other cardiac surgeons. This predicted 
challenge represents a barrier that may make surgeons 
hesitant to operate on achondroplastic dwarfs and decline 
surgical intervention for those who may benefit from an 
intervention. A prospective registry would further support 
the findings of this systematic review and help to eliminate 
operative concerns surgeons may have with respect to 
this population’s anatomy. This systematic review of 
the available literature suggests these procedures can be 
accomplished safely and effectively.
Limitations and future directions
Achondroplasia represents a relatively rare condition and 
therefore this systematic review encapsulates the minority 
of this small subgroup of patients undergoing cardiac 
interventions. Given this, most of the data in this systematic 
review comes from individual case reports, which are 
subject to a publication bias. Successful cases are more 
likely to be reported which is especially true here as these 
reports show excellent survival and low complication rates. 
Ideally, a prospective registry would follow patients with 
the necessary pre-operative characteristics following their 
intervention. However, a prospective database here is likely 
to suffer from a lower power given our current literature 
search only produced 14 of this particular type of patient. 
Our results with respect to survival and complications 
should be viewed with the understanding that the cases 
where patients did not survive may not be reported and 
therefore our survival is likely overestimated and our 
complications underestimated.
Conclusions
Common cardiac procedures can be performed with 
reasonable safety in patients with achondroplasia. Operative 
and procedural adjustments may need to be made with 
respect to equipment and technique to accommodate 
patient-specific needs.
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